期刊文献+

miR-29c对脑胶质瘤U251细胞生物学活性的影响 被引量:2

Effect of miR-29c on the biological behavior of human glioma cell U251
下载PDF
导出
摘要 目的探讨miR-29c对脑胶质瘤U251细胞生物学活性的影响及可能机制。方法体外培养胶质瘤U251细胞,实验组将miR-29c mimics转染至细胞,miR mimics转染作为对照组。应用实时荧光定量PCR检测转染后miR-29c表达量的改变,MTT实验测定细胞增殖,流式细胞术检测细胞凋亡情况,体外侵袭实验分析miR-29c转染后细胞的体外侵袭能力,Westernblot检测转染后转录因子YY1蛋白的表达。结果荧光定量PCR结果显示:实验组miR-29c表达量为(106.65±15.51),较对照组显著上调(P<0.01)。与对照组比较,实验组U251细胞的增殖能力明显降低(P<0.01),凋亡率增加(P<0.05),体外侵袭能力明显减弱(P<0.01),YY1蛋白表达下调(P<0.01)。结论 miR-29c可能通过调控YY1蛋白的表达抑制胶质瘤细胞的生物活性。 Objective To explore the effect of miR-29c on the biological activity of human glioma cell U251 and its probable mechanism. Methods miR-29c mimics were transfected into human glioma cell U251 cultured in vitro as experimental group and the miR mimics were taken as control group. The expression of miR-29c was measured by real-time fluorescence quantitative PCR (RT-PCR) after transfection. The cell proliferation was determined by MTT assay and cell apoptosis was assayed by flow cytometry (FCM). The invasive ability of U251 cells'was observed by Transwell invasion assay before and after transfection with miR-29c mimics. The expression of transcription factor YY1 protein was detected by Western blot. Results RT-PCR results showed that the expression of miR-29c in experimental group was 106.65 + 15.51 after transfection and significantly more than that in control group (P〈0.01). Compared with control group, the proliferation ability of U251 cells significantly decreased (P〈0.01), the cell apoptosis rate increased (P〈0.05), invasive ability in vitro was inhibited (P〈0.01) and the expression of YY1 protein down-regulated in the experimental group (P〈0.01). Conclusions miR-29c can inhibit the biological behavior of U251 cells, which may be attributed to the regulation of YY1 expression.
出处 《中国微侵袭神经外科杂志》 CAS 2012年第6期277-279,共3页 Chinese Journal of Minimally Invasive Neurosurgery
关键词 神经胶质瘤 微RNAS 蛋白 YY1 细胞增殖 细胞凋亡 glioma microRNAs protein, YY1 cell proliferation cell apoptosis
  • 相关文献

参考文献7

  • 1Barrel DP. MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 2004, 116(2): 281-297.
  • 2Chiang CW, Huang Y, Leong KW, et ol. PKCet mediated induction of miR-101 in human hepatoma HepG2 cells [J]. J Biomed Sci, 2010, 17(1): 35.
  • 3Yan LX, Huang XF, Shao Q, et td. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis [J]. RNA, 2008, 14(11): 2348-2360.
  • 4Gao W, Shen H, Liu L, et td. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis [J]. J Cancer Res Clin Oncol, 2011,137(4): 557-566.
  • 5Mott JL Kobayashi S, Bronk SF, et al. miR-29 regulates Mcl-1 protein expression and apoptosis [J]. Oncogene, 2007, 26(42): 6133-6140.
  • 6Chen QR, Yu LR, Tsang P, et td. Systematic proteome ana- lysis identifies transcription factor YYI as a direct target of miR-34a [J]. J Proteome Res, 2011, 10(2): 479-487.
  • 7Wang H, Garzon R, Sun H, et ~d. NF-kappa B-YYI-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomy- osarcoma [J]. Cancer Cell, 2008, 14(5): 369-381.

同被引文献12

  • 1LANDI D, MORENO V, GUINO E, et al. Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer[J]. Mutat Res,2011,717 (1-2):109-115.
  • 2LIU N, TANG L L, SUN Y, et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma[J]. Cancer Lett,2013,329(2): 181 - 188.
  • 3LIU L, YE J X, QIN Y Z, et al. Evaluation of miR-29c, miR- 124, miR-135a and miR-148a in predicting lymph node metastasis and tumor stage of gastric cancer[J]. Int J Clin Exp Med,2015,8(12): 22227-22236.
  • 4CRISTOBAL I, MADOZ-GURPIDE J, MANSO R, et al. MiR-29c downregulation contributes to metastatic progression in colorectal cancer[J]. Ann Oncol,2015,26(10):2199-2200.
  • 5YU Y, WANG Y, NIU Y, et al. Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c[J]. Am J Physiol Renal Physiol, 2015,309(7):595-603.
  • 6NONAKA R, MIYAKE Y, HATA T, et al. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer[J]. Int J Oncol,2015,47(3): 1097-1102.
  • 7LI L Z, ZHANG C Z, LIU L L, et al. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWISTI[J]. Carcinogenesis,2014,35(2):469-478.
  • 8李春生.脑胶质瘤患者血清miR-128和miR-720相对表达量及临床意义[J].标记免疫分析与临床,2013,20(4):242-245. 被引量:7
  • 9何涵,石羽,李青原,史家玮,李凌.miR-98对肝癌细胞增殖和侵袭能力的影响[J].中国热带医学,2014,14(1):16-19. 被引量:3
  • 10郭珊珊,朱仲玲,徐辉,丁凤霞,王国成,赵敏,阎昭.替莫唑胺酯对脑胶质瘤的作用及其机制研究[J].中国临床药理学杂志,2015,31(13):1271-1275. 被引量:16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部